Assessment of a novel transdermal selective β1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease
- 1 September 2017
- journal article
- clinical trial
- Published by Elsevier in Journal of Cardiology
- Vol. 70 (3) , 212-219
Abstract
No abstract availableKeywords
Funding Information
- Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24591074 and 15K09103)
This publication has 22 references indexed in Scilit:
- Idiopathic ventricular arrhythmiasJournal of Cardiology, 2016
- Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardiaJournal of Anesthesia, 2016
- Radiofrequency Ablation Versus Antiarrhythmic Medication for Treatment of Ventricular Premature Beats From the Right Ventricular Outflow TractCirculation: Arrhythmia and Electrophysiology, 2014
- Comparison of Efficacy and Safety Between Bisoprolol Transdermal Patch (TY‐0201) and Bisoprolol Fumarate Oral Formulation in Japanese Patients With Grade I or II Essential Hypertension: Randomized, Double‐Blind, Placebo‐Controlled StudyThe Journal of Clinical Hypertension, 2013
- Autonomic involvement in idiopathic premature ventricular contractionsClinical Research in Cardiology, 2013
- Relation of symptoms and symptom duration to premature ventricular complex–induced cardiomyopathyHeart Rhythm, 2012
- Left Ventricular Systolic Dysfunction Induced by Ventricular EctopyCirculation: Arrhythmia and Electrophysiology, 2011
- Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular functionHeart, 2009
- Edrophonium‐Induced Right Ventricular Outflow Tract TachycardiaPacing and Clinical Electrophysiology, 2005
- Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: A randomized placebo-controlled studyAmerican Heart Journal, 2002